53 related articles for article (PubMed ID: 23030680)
1. In vitro metabolism of the 5-hydroxytryptamine1B receptor antagonist elzasonan.
Kamel A; Colizza K; Obach RS
Xenobiotica; 2013 Apr; 43(4):368-78. PubMed ID: 23030680
[TBL] [Abstract][Full Text] [Related]
2. Metabolism, pharmacokinetics, and excretion of the 5-hydroxytryptamine1b receptor antagonist elzasonan in humans.
Kamel A; Obach RS; Colizza K; Wang W; O'Connell TN; Coelho RV; Kelley RM; Schildknegt K
Drug Metab Dispos; 2010 Nov; 38(11):1984-99. PubMed ID: 20668248
[TBL] [Abstract][Full Text] [Related]
3. Reevaluation of the microsomal metabolism of montelukast: major contribution by CYP2C8 at clinically relevant concentrations.
Filppula AM; Laitila J; Neuvonen PJ; Backman JT
Drug Metab Dispos; 2011 May; 39(5):904-11. PubMed ID: 21289076
[TBL] [Abstract][Full Text] [Related]
4. In vitro metabolism of magnolin and characterization of cytochrome P450 enzymes responsible for its metabolism in human liver microsomes.
Kim DK; Liu KH; Jeong JH; Ji HY; Oh SR; Lee HK; Lee HS
Xenobiotica; 2011 May; 41(5):358-71. PubMed ID: 21294626
[TBL] [Abstract][Full Text] [Related]
5. Identification of cytochrome P450 isoenzymes involved in metabolism of (+)-praeruptorin A, a calcium channel blocker, by human liver microsomes using ultra high-performance liquid chromatography coupled with tandem mass spectrometry.
Jing WH; Song YL; Yan R; Wang YT
J Pharm Biomed Anal; 2013 Apr; 77():175-88. PubMed ID: 23434495
[TBL] [Abstract][Full Text] [Related]
6. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
Prakash C; Wang W; O'Connell T; Johnson KA
Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
[TBL] [Abstract][Full Text] [Related]
7. Interspecies comparison and role of human cytochrome P450 and flavin-containing monooxygenase in hepatic metabolism of L-775,606, a potent 5-HT(1D) receptor agonist.
Prueksaritanont T; Lu P; Gorham L; Sternfeld F; Vyas KP
Xenobiotica; 2000 Jan; 30(1):47-59. PubMed ID: 10659950
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) by human liver microsomes: characterization of metabolic pathways and of cytochrome P450 isoforms involved.
Baek MS; Kim JY; Myung SW; Yim YH; Jeong JH; Kim DH
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):381-8. PubMed ID: 11259320
[TBL] [Abstract][Full Text] [Related]
9. Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes.
Subrahmanyam V; Renwick AB; Walters DG; Young PJ; Price RJ; Tonelli AP; Lake BG
Drug Metab Dispos; 2001 Aug; 29(8):1146-55. PubMed ID: 11454734
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
11. Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
Huskey SW; Dean DC; Miller RR; Rasmusson GH; Chiu SH
Drug Metab Dispos; 1995 Oct; 23(10):1126-35. PubMed ID: 8654202
[TBL] [Abstract][Full Text] [Related]
12. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes.
Fang J; McKay G; Song J; Remillrd A; Li X; Midha K
Drug Metab Dispos; 2001 Dec; 29(12):1638-43. PubMed ID: 11717183
[TBL] [Abstract][Full Text] [Related]
13. In vitro identification of cytochrome P450 isoforms responsible for the metabolism of 1-hydroxyl-2,3,5-trimethoxy-xanthone purified from Halenia elliptica D. Don.
Feng R; Zhou X; Tan XS; Or PM; Hu T; Fu J; Ma JY; Huang M; He CY; Shi JG; Che CT; Yeung JH; Wang Y
Chem Biol Interact; 2014 Mar; 210():12-9. PubMed ID: 24380714
[TBL] [Abstract][Full Text] [Related]
14. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
Kasahara M; Suzuki H; Komiya I
Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
[TBL] [Abstract][Full Text] [Related]
15. Novel metabolites of buprenorphine detected in human liver microsomes and human urine.
Chang Y; Moody DE; McCance-Katz EF
Drug Metab Dispos; 2006 Mar; 34(3):440-8. PubMed ID: 16381669
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P-450-mediated metabolism of the individual enantiomers of the antidepressant agent reboxetine in human liver microsomes.
Wienkers LC; Allievi C; Hauer MJ; Wynalda MA
Drug Metab Dispos; 1999 Nov; 27(11):1334-40. PubMed ID: 10534319
[TBL] [Abstract][Full Text] [Related]
17. Scaling drug biotransformation data from cDNA-expressed cytochrome P-450 to human liver: a comparison of relative activity factors and human liver abundance in studies of mirtazapine metabolism.
Störmer E; von Moltke LL; Greenblatt DJ
J Pharmacol Exp Ther; 2000 Nov; 295(2):793-801. PubMed ID: 11046120
[TBL] [Abstract][Full Text] [Related]
18. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of nobiletin, a polymethoxy-flavonoid, by human liver microsomes and cytochrome P450.
Koga N; Ohta C; Kato Y; Haraguchi K; Endo T; Ogawa K; Ohta H; Yano M
Xenobiotica; 2011 Nov; 41(11):927-33. PubMed ID: 21726170
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human liver cytochrome P450 enzymes involved in the metabolism of a new H+/K+-ATPase inhibitor KR-60436.
Ji HY; Lee HW; Kim HH; Choi JK; Lee HS
Toxicol Lett; 2005 Jan; 155(1):103-14. PubMed ID: 15585365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
